These results suggested that increased expression of AEG-1 and TS in repeated biopsy samples contributed to the development of resistance to pemetrexed chemotherapy treatment and caused lung cancer progression in patients with lung adenocarcinoma. Here, TYMS is linked to lung adenocarcinoma.